ZIOPHARM Oncology Inc (ZIOP) Social Stream
Ziopharm Oncology Inc (ZIOP) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ZIOP.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ZIOP's average price target has moved down $2.76 over the prior 41 weeks.
Over the past 41 weeks, ZIOP's average upside potential has been 83.19%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ZIOP Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 153 days, ZIOP's average broker recommendation rating improved by 0.12.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, Ziopharm Oncology Inc's average analyst price target is higher than 3.04% of them.
- In the context of all US stocks, Ziopharm Oncology Inc's variance in analysts' estimates is lower than -85.02% of them.
- In the context of stocks in the small market cap category, Ziopharm Oncology Inc's upside potential (average analyst target price relative to current price) is higher than 161.86% of them.
- Ziopharm Oncology Inc's number of analysts covering the stock is greater than 50.2% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, ZEAL, XOMA, and XLO are the three stocks most similar to Ziopharm Oncology Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding ZIOP using the data that counts. Try POWR Ratings for free.